Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Diseases, Interstitial × Clinical Protocols × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pneumonia 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

perflutren 1 Thoracoscopy 1 Sulfur Hexafluoride 1 Radiotherapy 1 Prednisone 1 Lidocaine 1 Drug Delivery Systems 1 Dexamethasone 1 Conscious Sedation 1 Clinical Protocols 1 Bronchoscopy 1 Blood Pressure 1 Adrenal Cortex Hormones 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡